期刊文献+

丙酮醛降低人脑微血管内皮细胞系hCMEC/D3细胞活力及线粒体膜电位

Methylglyoxal reduces cell viability and mitochondrion membrane potential of human brain microvascular endothelial cell line hCMEC/D3
下载PDF
导出
摘要 目的探讨丙酮醛(MGO)介导人脑微血管内皮细胞系hCMEC/D3的损伤作用及机制。方法不同浓度MGO(0.25、0.50、0.75、1.00和1.25 mmol/L)作用hCMEC/D3细胞24 h,用CCK-8法检测hCMEC/D3细胞活力;用试剂盒检测胞内乳酸脱氢酶(LDH)和超氧化物歧化酶(SOD)活性。线粒体膜电位检测试剂盒(JC-1)荧光探针检测线粒体膜电位水平,MitoSOX荧光探针观察线粒体活性氧(mROS)产生。结果MGO组与对照组相比,hCMEC/D3细胞活力呈浓度依赖性下降(P<0.01),细胞内LDH活性显著升高(P<0.01),同时SOD活性降低(P<0.01),差异有统计学意义。与对照组相比,MGO处理12 h后的hCMEC/D3细胞经JC-1染色红绿荧光比值降低,提示MGO诱导细胞线粒体膜电位下降。MitoSOX染色后,与对照组相比,MGO处理过的hCMEC/D3细胞的红色荧光表达数量增加,提示细胞内mROS过量生成。结论MGO降低hCMEC/D3细胞活力及线粒体膜电位,并诱导胞内mROS过量生成。 Objective To explore the effects and mechanism of methylglyoxal(MGO)in human brain microvascular endothelial cell line(hCMEC/D3).Methods The hCMEC/D3 cells were incubated with MGO(0.25,0.50,0.75,1.00 and 1.25 mmol/L)for 24 h.Cell viability was detected by CCK-8 assay.Cellular LDH and SOD activities were determined by commercially available kits.The change of mitochondrion membrane potential was assessed by JC-1 probe.MitoSOX probe was used to observe mitochondrial reactive oxygen species(mROS)release.Results Compared with control,cell viability of hCMEC/D3 treated with MGO decreased in a concentration-dependent manner(P<0.01).Increased LDH activity and decreased SOD activity were observed with MGO exposure(P<0.01).The decrease of mitochondrion membrane potential and the excessive increase of mROS were induced after MGO exposure for 12 h,which were detected by JC-1 or MitoSOX probe.Conclusions MGO reduces cell viability and mitochondria membrane potential in hCMEC/D3 cells with excessive mROS generation.
作者 李婷婷 韩臻平 高立 王思懿 钟恺 黄萍 严洁萍 LI Tingting;HAN Zhenping;GAO Li;WANG Siyi;ZHONG Kai;HUANG Ping;YAN Jieping(Center for Clinical Pharmacy,Department of Pharmacy,Zhejiang Provincial People′s Hospital,People′s Hospital Affiliated to Hangzhou Medical College,Hangzhou 310014;Department of Pharmacology,College of Pharmaceutical Sciences,Zhejiang University of Technology,Hangzhou 310014;Key Laboratory of Endocrine Gland Diseases of Zhejiang Province,Hangzhou 310014,China)
出处 《基础医学与临床》 2023年第11期1631-1635,共5页 Basic and Clinical Medicine
基金 国家自然科学基金(81903597) 浙江省自然科学基金(LQ16H310003) 浙江省医药卫生科技项目(2021KY016,2022KY061) 浙江省中医药科技计划(2023ZL015)。
关键词 糖尿病脑血管并发症 丙酮醛 人脑微血管内皮细胞系 膜电位 线粒体活性氧 diabetic cerebral vascular complication methylglyoxal human brain microvascular endothelial cells line membrane potential mitochondrial reactive oxygen species
  • 相关文献

参考文献2

二级参考文献17

  • 1王宗仁,马爱玲,郑瑾,张仲海,苏明权,方坤泉,岳乔红,李立文,张建芳.芪丹通脉片对动脉粥样硬化大鼠血清NO含量及动脉壁eNOS基因表达的影响[J].第四军医大学学报,2004,25(13):1225-1227. 被引量:12
  • 2郑玉宝,徐希岳,王启之.一氧化氮及内皮素对肝硬化患者动脉血氧分压的影响[J].实用全科医学,2006,4(2):140-141. 被引量:13
  • 3Small DL, Buchan AM. Mechanisms of cerebral ischemia: intracellular cascades and therapeutic interventions [ J ]. Cardiothorac Vasc Anesth, 1996, 10( 1 ) : 139 - 142.
  • 4Yan SF, Ramasamy R, Naka Y. Glycation, Inflammation, and RAGE: A scaffold for the macrovascular complications of diabetes and beyond [ J ]. Circulation Res, 2003, 93 (12) :1159 -1169.
  • 5Factor SM, Okun EM, Minase T. Capillary microaneurysms in the human diabetic heart [ J ]. N Engl J Med, 1980, 302:384 - 388.
  • 6Factor SM, Bhan R, Minase T, et al. Hypertensive diabetic cardiomyopathy in the rat: an experimental model of human disease[J]. Am J Pathol, 1981, 102:219 -228.
  • 7Fein FS, Sonnenblick EH. Diabetic cardiomyopathy [ J ] Cardiovasc Drugs Ther, 1994, 8 : 65 -73.
  • 8Gargiulo P, Giusti C, Pietrobono D, et al. Tamburrano Diabetes mellitus and retinopathy [ J ]. Dig Liver Dis, 2004, 36 (Suppl. 1) : 101 - 105.
  • 9Cook S. Coronary artery disease, nitric oxideand oxidative stress: the " Yin-Yang" effect-a Chinese concept for a worldwide pandemic Cardiology [ J ]. Swiss Med Wldy, 2006, 136 : 103 - 113.
  • 10Galen MP, Allan MR. The complex role of iNOS in acutelyrejecting cardiac transplants [ J ]. Free Radic Biol Med, 2008, 8 : 1536 - 1552.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部